Table 2.
Comparison of antioxidant defense markers in patients with type 2 diabetes and controls.
| Parameter | Type 2 diabetes | Control group | p |
|---|---|---|---|
| FRAP [mmol/L] | 0.97 ± 0.21 | 0.84 ± 0.16 | <0.001 |
| GPxplasma [U/L] | 235.7 (93.2–359.9) | 644.5 (466.0–798.8) | <0.001 |
| GPxhemolysate [U/gHb] | 43.8 ± 21.5 | 55.4 ± 25.9 | 0.002 |
| GRplasma [U/L] | 74.5 ± 21.3 | 43.7 ± 13.5 | <0.001 |
| GRhemolysate [U/gHb] | 33.0 (26.9–38.5) | 22.62 (16.2–29.1) | <0.001 |
| GSH [μmol/L] | 0.87 (0.46–2.23) | 0.92 (0.56–1.20) | 0.117 |
| Uric acid [μmol/L] | 364.3 ± 117.9 | 293.5 ± 85.7 | <0.001 |
| GGT [U/L] | 23.5 (11.5–37.5) | 10.5 (7.0–17.0) | <0.001 |
| CRP [mg/dL] | 1.95 (0.85–5.72) | 0.87 (0.46–2.23) | <0.001 |
Data are expressed as mean ± SD and median and interquartile range.